| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.057 | 0.2 |